Home > National Drug Code (NDC) > Irinotecan Hydrochloride

Irinotecan Hydrochloride - 61703-349-16 - (Irinotecan Hydrochloride)

Alphabetical Index


Drug Information of Irinotecan Hydrochloride

Product NDC: 61703-349
Proprietary Name: Irinotecan Hydrochloride
Non Proprietary Name: Irinotecan Hydrochloride
Active Ingredient(s): 20    mg/mL & nbsp;   Irinotecan Hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Irinotecan Hydrochloride

Product NDC: 61703-349
Labeler Name: Hospira Worldwide, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077915
Marketing Category: ANDA
Start Marketing Date: 20120416

Package Information of Irinotecan Hydrochloride

Package NDC: 61703-349-16
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (61703-349-16) > 2 mL in 1 VIAL, SINGLE-USE

NDC Information of Irinotecan Hydrochloride

NDC Code 61703-349-16
Proprietary Name Irinotecan Hydrochloride
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (61703-349-16) > 2 mL in 1 VIAL, SINGLE-USE
Product NDC 61703-349
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Irinotecan Hydrochloride
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120416
Marketing Category Name ANDA
Labeler Name Hospira Worldwide, Inc.
Substance Name IRINOTECAN HYDROCHLORIDE
Strength Number 20
Strength Unit mg/mL
Pharmaceutical Classes Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]

Complete Information of Irinotecan Hydrochloride


General Information